Clonidine - Ropivacaine in Peribulbar Anesthesia
Information source: Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov processed this data on August 23, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Indication for Surgery of the Posterior Segment Under Locoregional Anaesthesia
Intervention: 5 ml Ropivacaine 10% + physiological saline (Drug); 5 ml Ropivacaine 10% + Clonidine 1 µg/kg (Drug)
Phase: Phase 2
Status: Completed
Sponsored by: Centre Hospitalier Universitaire Dijon
Summary
This is a study conducted in 60 patients, randomly assigned to one of two groups of 30: the
first will receive ropivacaine alone and the second will receive the association
ropivacaine/clonidine.
The aim of the study is to prove that the association of Clonidine with Ropivacaine is more
effective than ropivacaine alone for locoregional anaesthesia of the eye for retinal
surgery.
The principal interest of this association of drugs is that it procures faster and longer
anaesthesia of the eye with less ropivacaine (therefore fewer injections). This provides
greater comfort to the patient during and after the intervention.
Clinical Details
Official title: Prospective Randomised Double-blind Study to Compare Ropivacaine 10mg/mL Alone Versus Ropivacaine 10mg/mL Associated With Clonidine 1µg/kg for Peribulbar Anesthesia in Posterior Eye Surgery
Study design: Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment
Primary outcome: Dose of ropivacaine injected 10 mg/ml: necessary to obtain complete ocular akinesia
Secondary outcome: Time to achieve akinesia
Eligibility
Minimum age: 18 Years.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- patients who have given written informed consent
- any adult patient about to undergo their first operation involving the posterior
segment of the eye under peribulbar anaesthesia
Exclusion Criteria:
- persons without National Health Insurance
- pregnant or breast-feeding women, patients < 18, patients who cannot give their
consent, patient's refusal of Loco-Regional Anesthesia, patients who cannot remain in
dorsal decubitus dorsal for at least 1h
- contra-indication for Loco-Regional Anesthesia
- hypersensitivity to the study drugs (ropivacaine, clonidine), to the corresponding
excipients or hypersensitivity to local anaesthetics other than amide-type
ropivacaine.
- disorders of periorbital or oculomotor sensitivity, patients with glaucoma, patients
with chronic pain and on morphines
- uncontrolled arterial hypertension, clonidine per os at home, arterial hypotension
before the intervention (SAP < 90 mmHg)
- Surgery for diabetic retinopathy, patients with unbalanced diabetes, eye with prior
posterior segment surgery
- Contra-indications mentioned on the summary of product characteristics for clonidine
(known hypersensitivity to the active ingredients or one of its excipients, Heart
rate below 60bpm, severe Bradycardia due to sinoatrial node disease or second or
third degree atrioventricular block, Depression, Sultopride).
Locations and Contacts
CHU Dijon, Dijon 21, France
Additional Information
Starting date: August 2013
Last updated: October 11, 2013
|